The Trump administration's Medicare director is working to manage expectations around TrumpRx, the administration's drug pricing initiative. The effort comes as the administration positions its healthcare policies as a key issue for the upcoming midterm elections.
The move suggests potential challenges or delays in implementing the drug pricing program that the administration had previously promoted. Managing expectations often signals that initial goals may not be met within the originally anticipated timeline.